{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:29:12Z","timestamp":1747153752395,"version":"3.40.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:00:00Z","timestamp":1640908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:00:00Z","timestamp":1640908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00253-021-11747-4","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T06:02:32Z","timestamp":1640930552000},"page":"579-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications"],"prefix":"10.1007","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3694-8982","authenticated-orcid":false,"given":"Ernesto","family":"Garay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5109-7637","authenticated-orcid":false,"given":"Diego","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lautaro","family":"Leschiutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3069-0108","authenticated-orcid":false,"given":"Ricardo","family":"Kratje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-0153","authenticated-orcid":false,"given":"Claudio","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,31]]},"reference":[{"key":"11747_CR1","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1016\/j.vaccine.2020.03.001","volume":"38","author":"S Aston-Deaville","year":"2020","unstructured":"Aston-Deaville S, Carlsson E, Saleem M, Thistlethwaite A, Chan H, Maharjan S, Facchetti A, Feavers IM, Alistair Siebert C, Collins RF, Roseman A, Derrick JP (2020) An assessment of the use of hepatitis B virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis. Vaccine 38:3201\u20133209. https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.001","journal-title":"Vaccine"},{"key":"11747_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jmgm.2009.08.006","volume":"28","author":"H Azuma","year":"2009","unstructured":"Azuma H, Yoneda S (2009) Structure and dynamics of the GH loop of the foot-and-mouth disease virus capsid. J Mol Graph Model 28:278\u2013286. https:\/\/doi.org\/10.1016\/j.jmgm.2009.08.006","journal-title":"J Mol Graph Model"},{"key":"11747_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hep.26132","volume":"57","author":"E Beaumont","year":"2013","unstructured":"Beaumont E, Patient R, Hourioux C, Dimier-Poisson I, Roingeard P (2013) Chimeric hepatitis B virus\/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine. Hepatology 57:1303\u20131313. https:\/\/doi.org\/10.1002\/hep.26132","journal-title":"Hepatology"},{"key":"11747_CR4","doi-asserted-by":"publisher","first-page":"e1008383","DOI":"10.1371\/journal.ppat.1008383","volume":"16","author":"L Belot","year":"2020","unstructured":"Belot L, Ouldali M, Roche S, Legrand P, Gaudin Y, Albertini AA (2020) Crystal structure of Mokola virus glycoprotein in its post-fusion conformation. PLoS Pathog 16:e1008383. https:\/\/doi.org\/10.1371\/journal.ppat.1008383","journal-title":"PLoS Pathog"},{"key":"11747_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","volume":"27","author":"P Benkert","year":"2011","unstructured":"Benkert P, Biasini M, Schwede T (2011) Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 27:343\u2013350. https:\/\/doi.org\/10.1093\/bioinformatics\/btq662","journal-title":"Bioinformatics"},{"key":"11747_CR6","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1007\/978-3-642-70060-6_1","volume":"65","author":"A Benmansour","year":"1991","unstructured":"Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, Flamand A, Lafay F (1991) Antigenicity of rabies virus glycoprotein. J Virol 65:4198\u20134203. https:\/\/doi.org\/10.1007\/978-3-642-70060-6_1","journal-title":"J Virol"},{"key":"11747_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1385\/CBB:44:3:313","volume":"44","author":"MC Bonaldo","year":"2006","unstructured":"Bonaldo MC, Garratt RC, Freire MS, Galler R (2006) Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein. Cell Biochem Biophys 44:313\u2013324. https:\/\/doi.org\/10.1385\/CBB:44:3:313","journal-title":"Cell Biochem Biophys"},{"key":"11747_CR8","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1128\/JVI.00577-06","volume":"80","author":"A Burman","year":"2006","unstructured":"Burman A, Clark S, Abrescia NGA, Fry EE, Stuart DI, Jackson T (2006) Specificity of the VP1 GH Loop of foot-and-mouth disease virus for \u03b1v integrins. J Virol 80:9798\u20139810. https:\/\/doi.org\/10.1128\/JVI.00577-06","journal-title":"J Virol"},{"key":"11747_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.virol.2016.08.034","volume":"498","author":"SG Buthelezi","year":"2016","unstructured":"Buthelezi SG, Dirr HW, Chakauya E, Chikwamba R, Martens L, Tsekoa TL, Stoychev SH, Vandermarliere E (2016) The Lyssavirus glycoprotein: a key to cross-immunity. Virology 498:250\u2013256. https:\/\/doi.org\/10.1016\/j.virol.2016.08.034","journal-title":"Virology"},{"key":"11747_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1586\/14760584.6.3.381","volume":"6","author":"B Chackerian","year":"2007","unstructured":"Chackerian B (2007) Virus-like particles: flexible platforms for vaccine development. Expert Rev Vaccines 6:381\u2013390. https:\/\/doi.org\/10.1586\/14760584.6.3.381","journal-title":"Expert Rev Vaccines"},{"key":"11747_CR11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/bit.26890","volume":"116","author":"HK Charlton Hume","year":"2019","unstructured":"Charlton Hume HK, Vidigal J, Carrondo MJT, Middelberg APJ, Rold\u00e3o A, Lua LHL (2019) Synthetic biology for bioengineering virus-like particle vaccines. Biotechnol Bioeng 116:919\u2013935. https:\/\/doi.org\/10.1002\/bit.26890","journal-title":"Biotechnol Bioeng"},{"key":"11747_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/330381a0","volume":"330","author":"BE Clarke","year":"1987","unstructured":"Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, Syred AD, Highfield PE, Rowlands DJ, Brown F (1987) Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330:381\u2013384. https:\/\/doi.org\/10.1038\/330381a0","journal-title":"Nature"},{"key":"11747_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines8020294","volume":"8","author":"A Czarnota","year":"2020","unstructured":"Czarnota A, Anna O, Pihl AF, Prentoe J (2020) Specific antibodies induced by immunization with hepatitis B virus-like particles carrying hepatitis C virus envelope glycoprotein 2 epitopes show differential neutralization efficiency. Vaccine 8:1\u201319. https:\/\/doi.org\/10.3390\/vaccines8020294","journal-title":"Vaccine"},{"key":"11747_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virusres.2016.08.007","volume":"224","author":"A del Carmen Mor\u00e1n-Garc\u00eda","year":"2016","unstructured":"del Carmen Mor\u00e1n-Garc\u00eda A, Rivera-Toledo E, Echeverr\u00eda O, V\u00e1zquez-Nin G, G\u00f3mez B, Bustos-Jaimes I (2016) Peptide presentation on primate erythroparvovirus 1 virus-like particles: in vitro assembly, stability and immunological properties. Virus Res 224:12\u201318. https:\/\/doi.org\/10.1016\/j.virusres.2016.08.007","journal-title":"Virus Res"},{"issue":"233","key":"11747_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.2425433","volume":"80","author":"F Delpeyroux","year":"1986","unstructured":"Delpeyroux F, Chenciner N, Lim A, Malpi\u00e8ce Y, Blondel B, Crainic R, Van Der Werf S, Streeck RE (1986) A poliovirus neutralizaton epitope expressed on hybrid hepatitis B surface antigen particles. Science 80(233):472\u2013475. https:\/\/doi.org\/10.1126\/science.2425433","journal-title":"Science"},{"key":"11747_CR16","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1099\/0022-1317-80-9-2343","volume":"80","author":"E Desm\u00e9zi\u00e8res","year":"1999","unstructured":"Desm\u00e9zi\u00e8res E, Jacob Y, Saron MF, Delpeyroux F, Tordo N, Perrin P (1999) Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines. J Gen Virol 80:2343\u20132351. https:\/\/doi.org\/10.1099\/0022-1317-80-9-2343","journal-title":"J Gen Virol"},{"key":"11747_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-4939-1417-3_9","volume":"2014","author":"B Donaldson","year":"2015","unstructured":"Donaldson B, Al-Barwani F, Young V, Scullion S, Ward V, Young S (2015) Virus-like particles, a versatile subunit vaccine platform. Adv Deliv Sci Technol 2014:159\u2013180. https:\/\/doi.org\/10.1007\/978-1-4939-1417-3_9","journal-title":"Adv Deliv Sci Technol"},{"key":"11747_CR18","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463\u20138471. https:\/\/doi.org\/10.1128\/JVI.72.11.8463-8471.1998","journal-title":"J Virol"},{"doi-asserted-by":"publisher","unstructured":"Eswar N, Webb B, Marti-renom MA, Madhusudhan MS, Eramian D, Shen M, Pieper U, Sali A (2006) Comparative protein structure modeling using modeller. Curr Protoc Bioinformatics 2006;Chapter 5:Unit-5.6. https:\/\/doi.org\/10.1002\/cpbi.3","key":"11747_CR19","DOI":"10.1002\/cpbi.3"},{"key":"11747_CR20","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.vaccine.2014.02.031","volume":"32","author":"D Fontana","year":"2014","unstructured":"Fontana D, Kratje R, Etcheverrigaray M, Prieto C (2014) Rabies virus-like particles expressed in HEK293 cells. Vaccine 32:2799\u20132804. https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.031","journal-title":"Vaccine"},{"key":"11747_CR21","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1016\/j.vaccine.2015.03.088","volume":"33","author":"D Fontana","year":"2015","unstructured":"Fontana D, Kratje R, Etcheverrigaray M, Prieto C (2015) Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate. Vaccine 33:4238\u20134246. https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.088","journal-title":"Vaccine"},{"key":"11747_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cimid.2019.04.009","volume":"65","author":"D Fontana","year":"2019","unstructured":"Fontana D, Marsili F, Garay E, Battagliotti J, Etcheverrigaray M, Kratje R, Prieto C (2019) A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications. Comp Immunol Microbiol Infect Dis 65:70\u201375. https:\/\/doi.org\/10.1016\/j.cimid.2019.04.009","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"11747_CR23","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1007\/s00253-020-10490-6","volume":"104","author":"D Fontana","year":"2020","unstructured":"Fontana D, Rodriguez MC, Garay E, Russo S, Prieto C (2020) Optimization and validation of a blocking ELISA for quantitation of anti-rabies immunoglobulins in multispecies sera. Appl Microbiol Biotechnol 104:4127\u20134139. https:\/\/doi.org\/10.1007\/s00253-020-10490-6","journal-title":"Appl Microbiol Biotechnol"},{"key":"11747_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2016.03.001","volume":"18","author":"KM Frietze","year":"2016","unstructured":"Frietze KM, Peabody DS, Chackerian B (2016) Engineering virus-like particles as vaccine platforms. Curr Opin Virol 18:44\u201349. https:\/\/doi.org\/10.1016\/j.coviro.2016.03.001","journal-title":"Curr Opin Virol"},{"key":"11747_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","volume":"187","author":"Y Gaudin","year":"1992","unstructured":"Gaudin Y, Ruigrok RW, Tuffereau C, Knossow M, Flamand A (1992) Rabies virus glycoprotein is a trimer. Virology 187:627\u2013632. https:\/\/doi.org\/10.1016\/0042-6822(92)90465-2","journal-title":"Virology"},{"key":"11747_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/viro.2000.0392","volume":"273","author":"A Gedvilaite","year":"2000","unstructured":"Gedvilaite A, Fr\u00f6mmel C, Sasnauskas K, Micheel B, \u00d6zel M, Behrsing O, Staniulis J, Jandrig B, Scherneck S, Ulrich R (2000) Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Virology 273:21\u201335. https:\/\/doi.org\/10.1006\/viro.2000.0392","journal-title":"Virology"},{"key":"11747_CR27","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1093\/infdis\/171.6.1576","volume":"171","author":"DM Gordon","year":"1995","unstructured":"Gordon DM, McGovern TW, Krzych U, Cohen JC, Schneider I, LaChance R, Heppner DG, Yuan G, Hollingdale M, Slaoui M (1995) Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis 171:1576\u20131585. https:\/\/doi.org\/10.1093\/infdis\/171.6.1576","journal-title":"J Infect Dis"},{"key":"11747_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","volume":"40","author":"EVL Grgacic","year":"2006","unstructured":"Grgacic EVL, Anderson DA (2006) Virus-like particles: passport to immune recognition. Methods 40:60\u201365. https:\/\/doi.org\/10.1016\/j.ymeth.2006.07.018","journal-title":"Methods"},{"key":"11747_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.17.2.465","volume":"17","author":"M Grubman","year":"2004","unstructured":"Grubman M, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17:465\u2013493. https:\/\/doi.org\/10.1128\/CMR.17.2.465","journal-title":"Clin Microbiol Rev"},{"key":"11747_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0003709","volume":"9","author":"K Hampson","year":"2015","unstructured":"Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, Costa P, Freuling CM, Hiby E, Knopf L, Leanes F, Meslin FX, Metlin A, Miranda ME, M\u00fcller T, Nel LH, Recuenco S, Rupprecht CE, Schumacher C, Taylor L, Vigilato MAN, Zinsstag J, Dushoff J (2015) Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis 9:1\u201320. https:\/\/doi.org\/10.1371\/journal.pntd.0003709","journal-title":"PLoS Negl Trop Dis"},{"key":"11747_CR31","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.vaccine.2016.02.047","volume":"34","author":"G Hu","year":"2016","unstructured":"Hu G, Wang N, Yu W, Wang Z, Zou Y, Zhang Y, Wang A, Deng Z, Yang Y (2016) Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B. Vaccine 34:1896\u20131903. https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.047","journal-title":"Vaccine"},{"key":"11747_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","volume":"73","author":"C Jallet","year":"1999","unstructured":"Jallet C, Jacob Y, Bahloul C, Drings A, Desmezieres E, Tordo N, Perrin P (1999) Chimeric lyssavirus glycoproteins with increased immunological potential. J Virol 73:225\u2013233. https:\/\/doi.org\/10.1128\/JVI.73.1.225-233.1999","journal-title":"J Virol"},{"key":"11747_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12275-017-7058-3","volume":"55","author":"H Jeong","year":"2017","unstructured":"Jeong H, Seong BL (2017) Exploiting virus-like particles as innovative vaccines against emerging viral infections. J Microbiol 55:220\u2013230. https:\/\/doi.org\/10.1007\/s12275-017-7058-3","journal-title":"J Microbiol"},{"doi-asserted-by":"publisher","unstructured":"Katz ISS, Guedes F, Fernandes ER, Dos Ramos Silva S (2017) Immunological aspects of rabies: a literature review. Arch Virol 1\u201318. https:\/\/doi.org\/10.1007\/s00705-017-3484-0","key":"11747_CR34","DOI":"10.1007\/s00705-017-3484-0"},{"key":"11747_CR35","doi-asserted-by":"publisher","first-page":"10541","DOI":"10.1007\/s00253-018-9361-2","volume":"102","author":"X Li","year":"2018","unstructured":"Li X, Meng X, Wang S, Li Z, Yang L, Tu L, Diao W, Yu C, Yu Y, Yan C, Wang L (2018) Virus-like particles of recombinant PCV2b carrying FMDV-VP1 epitopes induce both anti-PCV and anti-FMDV antibody responses. Appl Microbiol Biotechnol 102:10541\u201310550. https:\/\/doi.org\/10.1007\/s00253-018-9361-2","journal-title":"Appl Microbiol Biotechnol"},{"key":"11747_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/bit.25159","volume":"111","author":"LHL Lua","year":"2014","unstructured":"Lua LHL, Connors NK, Sainsbury F, Chuan YP, Wibowo N, Middelberg APJ (2014) Bioengineering virus-like particles as vaccines. Biotechnol Bioeng 111:425\u2013440. https:\/\/doi.org\/10.1002\/bit.25159","journal-title":"Biotechnol Bioeng"},{"key":"11747_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/3-540-27109-0_1","volume":"288","author":"BWJ Mahy","year":"2005","unstructured":"Mahy BWJ (2005) Introduction and history of foot-and-mouth disease virus. Curr Top Microbiol Immunol 288:1\u20138. https:\/\/doi.org\/10.1007\/3-540-27109-0_1","journal-title":"Curr Top Microbiol Immunol"},{"key":"11747_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00253-015-6973-7","volume":"100","author":"VA Mareze","year":"2016","unstructured":"Mareze VA, Borio CS, Bilen MF, Fleith R, Mirazo S, Mansur DS, Arbiza J, Lozano ME, Bru\u00f1a-Romero O (2016) Tests in mice of a dengue vaccine candidate made of chimeric Junin virus-like particles and conserved dengue virus envelope sequences. Appl Microbiol Biotechnol 100:125\u2013133. https:\/\/doi.org\/10.1007\/s00253-015-6973-7","journal-title":"Appl Microbiol Biotechnol"},{"key":"11747_CR39","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1128\/JVI.01931-09","volume":"84","author":"LW McGinnes","year":"2010","unstructured":"McGinnes LW, Pantua H, Laliberte JP, Gravel KA, Jain S, Morrison TG (2010) Assembly and biological and immunological properties of Newcastle disease virus-like particles. J Virol 84:4513\u20134523. https:\/\/doi.org\/10.1128\/JVI.01931-09","journal-title":"J Virol"},{"key":"11747_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","volume":"34","author":"MO Mohsen","year":"2017","unstructured":"Mohsen MO, Zha L, Cabral-Miranda G, Bachmann MF (2017) Major findings and recent advances in virus\u2013like particle (VLP)-based vaccines. Semin Immunol 34:123\u2013132. https:\/\/doi.org\/10.1016\/j.smim.2017.08.014","journal-title":"Semin Immunol"},{"key":"11747_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini L, Bl\u00f6mer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263\u2013267. https:\/\/doi.org\/10.1126\/science.272.5259.263","journal-title":"Science"},{"key":"11747_CR42","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"11747_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/biot.201400427","volume":"10","author":"GP Pijlman","year":"2015","unstructured":"Pijlman GP (2015) Enveloped virus-like particles as vaccines against pathogenic arboviruses. Biotechnol J 10:659\u2013670. https:\/\/doi.org\/10.1002\/biot.201400427","journal-title":"Biotechnol J"},{"issue":"Suppl 8","key":"11747_CR44","doi-asserted-by":"publisher","first-page":"P7","DOI":"10.1186\/1753-6561-5-S8-P7","volume":"5","author":"C Prieto","year":"2011","unstructured":"Prieto C, Fontana D, Etcheverrigaray M, Kratje R (2011) A strategy to obtain recombinant cell lines with high expression levels. Lentiviral Vector-Mediated Transgenesis. BMC Proc 5(Suppl 8):P7. https:\/\/doi.org\/10.1186\/1753-6561-5-S8-P7","journal-title":"BMC Proc"},{"key":"11747_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1586\/erv.11.37","volume":"10","author":"R Raghunandan","year":"2011","unstructured":"Raghunandan R (2011) Virus-like particles: innate immune stimulators. Expert Rev Vaccines 10:409\u2013411. https:\/\/doi.org\/10.1586\/erv.11.37","journal-title":"Expert Rev Vaccines"},{"key":"11747_CR46","doi-asserted-by":"publisher","first-page":"e0006191","DOI":"10.1371\/journal.pntd.0006191","volume":"12","author":"V Ramasamy","year":"2018","unstructured":"Ramasamy V, Arora U, Shukla R, Poddar A, Shanmugam RK, White LJ, Mattocks MM, Raut R, Perween A, Tyagi P, de Silva AM, Bhaumik SK, Kaja MK, Villinger F, Ahmed R, Johnston RE, Swaminathan S, Khanna N (2018) A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice. PLoS Negl Trop Dis 12:e0006191. https:\/\/doi.org\/10.1371\/journal.pntd.0006191","journal-title":"PLoS Negl Trop Dis"},{"key":"11747_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1006\/viro.2002.1429","volume":"297","author":"S Roche","year":"2002","unstructured":"Roche S, Gaudin Y (2002) Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. Virology 297:128\u2013135. https:\/\/doi.org\/10.1006\/viro.2002.1429","journal-title":"Virology"},{"key":"11747_CR48","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1135710","volume":"315","author":"S Roche","year":"2007","unstructured":"Roche S, Rey FA, Gaudin Y, Bressanelli S (2007) Structure of the Prefusion Form of VSV G. Science (80-) 315:843\u2013848. https:\/\/doi.org\/10.1126\/science.1135710","journal-title":"Science (80-)"},{"key":"11747_CR49","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1586\/erv.10.115","volume":"9","author":"A Rold\u00e3o","year":"2010","unstructured":"Rold\u00e3o A, Mellado MCM, Castilho LR, Carrondo MJT, Alves PM (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9:1149\u20131176. https:\/\/doi.org\/10.1586\/erv.10.115","journal-title":"Expert Rev Vaccines"},{"key":"11747_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"RTS SCTP","year":"2015","unstructured":"RTS SCTP (2015) Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386:31\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(15)60721-8","journal-title":"Lancet"},{"key":"11747_CR51","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: An open-source platform for biological-image analysis. Nat Methods 9:676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"11747_CR52","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, S\u00f6ding J, Thompson JD, Higgins DG (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539. https:\/\/doi.org\/10.1038\/msb.2011.75","journal-title":"Mol Syst Biol"},{"key":"11747_CR53","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","volume":"107","author":"T Vicente","year":"2011","unstructured":"Vicente T, Rold\u00e3o A, Peixoto C, Carrondo MJT, Alves PM (2011) Large-scale production and purification of VLP-based vaccines. J Invertebr Pathol 107:S42\u2013S48. https:\/\/doi.org\/10.1016\/j.jip.2011.05.004","journal-title":"J Invertebr Pathol"},{"key":"11747_CR54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/135965350701200409","volume":"12","author":"PTK Vietheer","year":"2007","unstructured":"Vietheer PTK, Boo I, Drummer HE, Netter HJ (2007) Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Antivir Ther 12:477\u2013487","journal-title":"Antivir Ther"},{"key":"11747_CR55","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.chom.2013.08.012","volume":"14","author":"J Votteler","year":"2013","unstructured":"Votteler J, Sundquist WI (2013) Virus budding and the ESCRT pathway. Cell Host Microbe 14:232\u2013241. https:\/\/doi.org\/10.1016\/j.chom.2013.08.012","journal-title":"Cell Host Microbe"},{"key":"11747_CR56","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ (2009) Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189\u20131191. https:\/\/doi.org\/10.1093\/bioinformatics\/btp033","journal-title":"Bioinformatics"},{"unstructured":"World Health Organization (2018) WHO Expert Consultation on rabies. WHO Technical Report Series No. 1012","key":"11747_CR57"},{"key":"11747_CR58","doi-asserted-by":"publisher","first-page":"12973","DOI":"10.1038\/srep12973","volume":"5","author":"L Xu","year":"2015","unstructured":"Xu L, He D, Yang L, Li Z, Ye X, Yu H, Zhao H, Li S, Yuan L, Qian H, Que Y, Kuo Shih JW, Zhu H, Li Y, Cheng T, Xia N (2015) A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71. Sci Rep 5:12973. https:\/\/doi.org\/10.1038\/srep12973","journal-title":"Sci Rep"},{"doi-asserted-by":"publisher","unstructured":"Yan D, Wei Y-Q, Guo H-C, Sun S-Q (2015) The application of virus-like particles as vaccines and biological vehicles. Appl Microbiol Biotechnol 10415\u201310432. https:\/\/doi.org\/10.1007\/s00253-015-7000-8","key":"11747_CR59","DOI":"10.1007\/s00253-015-7000-8"},{"key":"11747_CR60","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-3083.2007.01900.x","volume":"65","author":"YL Zhang","year":"2007","unstructured":"Zhang YL, Guo YJ, Wang KY, Lu K, Li K, Zhu Y, Sun SH (2007) Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Scand J Immunol 65:320\u2013328. https:\/\/doi.org\/10.1111\/j.1365-3083.2007.01900.x","journal-title":"Scand J Immunol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-021-11747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-021-11747-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-021-11747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:57:14Z","timestamp":1744196234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-021-11747-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,31]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["11747"],"URL":"https:\/\/doi.org\/10.1007\/s00253-021-11747-4","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"type":"print","value":"0175-7598"},{"type":"electronic","value":"1432-0614"}],"subject":[],"published":{"date-parts":[[2021,12,31]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}